These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 20139835)

  • 1. Tc-99m hynic octreotide SPECT-MRI in brain metastasis of thyroid papillary-insular cancer.
    Gambini JP; Núñez M; Vila R; Noble J; Alonso O
    Clin Nucl Med; 2009 Dec; 34(12):920-1. PubMed ID: 20139835
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical usefulness of fusion of 131I SPECT and CT images in patients with differentiated thyroid carcinoma.
    Yamamoto Y; Nishiyama Y; Monden T; Matsumura Y; Satoh K; Ohkawa M
    J Nucl Med; 2003 Dec; 44(12):1905-10. PubMed ID: 14660715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Value of combined technetium-99m hydroxy methylene diphosphonate and thallium-201 imaging in detecting bone metastases from thyroid carcinoma.
    Alam MS; Takeuchi R; Kasagi K; Misaki T; Miyamoto S; Iida Y; Hidaka A; Konishi J
    Thyroid; 1997 Oct; 7(5):705-12. PubMed ID: 9349573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detecting metastatic neck lymph nodes in papillary thyroid carcinoma by 18F-2-deoxyglucose positron emission tomography and Tc-99m tetrofosmin single photon emission computed tomography.
    Wu YJ; Wu HS; Yen RF; Shen YY; Kao CH
    Anticancer Res; 2003; 23(3C):2973-6. PubMed ID: 12926147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is there a role for sandostatin treatment in patients with progressive thyroid cancer and iodine-negative but somatostatin-receptor-positive metastases?
    Kohlfuerst S; Igerc I; Gallowitsch HJ; Gomez I; Kresnik E; Matschnig S; Lind P
    Thyroid; 2006 Nov; 16(11):1113-9. PubMed ID: 17123338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isolated solitary recurrent skull metastasis in papillary thyroid carcinoma.
    Naik D; Jebasingh FK; Prabhu K; Thomas N
    BMJ Case Rep; 2018 Apr; 2018():. PubMed ID: 29700219
    [No Abstract]   [Full Text] [Related]  

  • 7. Solitary bone and brain metastasis in a patient with papillary thyroid carcinoma mimicking cavernous angioma.
    Han E; Lee YY; Kim E; Kwon SY; Kim SP; Kim HS; Kim MK
    Korean J Intern Med; 2016 Sep; 31(5):991-4. PubMed ID: 26813573
    [No Abstract]   [Full Text] [Related]  

  • 8. Incidental findings with Tc-99m MIBI imaging for parathyroid adenoma.
    Hustad KV; Staub UH; Bud Mi; Hardersen R; Jaeger S; Brekke OL
    Clin Nucl Med; 2007 Jul; 32(7):548-50. PubMed ID: 17581343
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparison of (18)F-FDG, (131)I-Na, and (201)Tl in diagnosis of recurrent or metastatic thyroid carcinoma.
    Shiga T; Tsukamoto E; Nakada K; Morita K; Kato T; Mabuchi M; Yoshinaga K; Katoh C; Kuge Y; Tamaki N
    J Nucl Med; 2001 Mar; 42(3):414-9. PubMed ID: 11337516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sternal metastasis as first presentation of a well-differentiated papillary thyroid carcinoma.
    Spartalis E; Moris D; Tomos P
    Surgery; 2017 Dec; 162(6):1336-1337. PubMed ID: 28237641
    [No Abstract]   [Full Text] [Related]  

  • 11. Iodine-123 uptake in vertebral haemangiomas in a patient with papillary thyroid carcinoma.
    Khan S; Dunn J; Strickland N; Al-Nahhas A
    Nucl Med Rev Cent East Eur; 2008; 11(1):30-3. PubMed ID: 19173186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Respective roles of thyroglobulin, radioiodine imaging, and positron emission tomography in the assessment of thyroid cancer.
    Lind P; Kohlfürst S
    Semin Nucl Med; 2006 Jul; 36(3):194-205. PubMed ID: 16762610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Technetium-99m-tetrofosmin whole-body scintigraphy in the follow-up of differentiated thyroid carcinoma.
    Lind P; Gallowitsch HJ; Langsteger W; Kresnik E; Mikosch P; Gomez I
    J Nucl Med; 1997 Mar; 38(3):348-52. PubMed ID: 9074515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Value of FDG PET in papillary thyroid carcinoma with negative 131I whole-body scan.
    Chung JK; So Y; Lee JS; Choi CW; Lim SM; Lee DS; Hong SW; Youn YK; Lee MC; Cho BY
    J Nucl Med; 1999 Jun; 40(6):986-92. PubMed ID: 10452315
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Fusion of SPECT with computed tomography or magnetic resonance for the interpretation of abnormal tracer uptake].
    Aqueveque A C; González E P; Gutiérrez B D; Jaimovich F R; Díaz P JC; Csendes G P; Orellana P P; Lavados M H; Alliende G I; Araya L S
    Rev Med Chil; 2007 Jun; 135(6):725-34. PubMed ID: 17728898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nuclear medicine approaches in the monitoring of thyroid cancer patients.
    Sergieva S; Hadjieva T; Doldurova M; Stefanova S; Dudov A
    J BUON; 2006; 11(4):511-8. PubMed ID: 17309186
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between expression of the sodium/iodide symporter and 131I uptake in recurrent lesions of differentiated thyroid carcinoma.
    Min JJ; Chung JK; Lee YJ; Jeong JM; Lee DS; Jang JJ; Lee MC; Cho BY
    Eur J Nucl Med; 2001 May; 28(5):639-45. PubMed ID: 11383871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Additional benefit of SPECT/CT in bone scanning of metastatic renal cell carcinoma.
    Bailey E; HoShon I; Roach P
    Clin Nucl Med; 2007 May; 32(5):411-4. PubMed ID: 17452879
    [No Abstract]   [Full Text] [Related]  

  • 19. Tc-99m sestamibi and In-111 pentetreotide uptake in metastatic papillary thyroid carcinoma.
    Lee J; Cutrone JA; Marcus CS
    Clin Nucl Med; 1995 Oct; 20(10):867-8. PubMed ID: 8616988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of 99mTc-sestamibi scintigraphy in multiple myeloma.
    Pace L; Salvatore M; Del Vecchio S
    J Nucl Med; 2006 Mar; 47(3):555. PubMed ID: 16513630
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.